Bliss GVS Pharma Statistics
Total Valuation
NSE:BLISSGVS has a market cap or net worth of INR 12.45 billion. The enterprise value is 11.58 billion.
Market Cap | 12.45B |
Enterprise Value | 11.58B |
Important Dates
The next estimated earnings date is Wednesday, April 30, 2025.
Earnings Date | Apr 30, 2025 |
Ex-Dividend Date | Jul 18, 2024 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.07% |
Shares Change (QoQ) | -1.02% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 40.49M |
Valuation Ratios
The trailing PE ratio is 20.89.
PE Ratio | 20.89 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 1.24 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 19.42 |
EV / Sales | 1.43 |
EV / EBITDA | 8.47 |
EV / EBIT | 10.95 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.09 |
Debt / EBITDA | 0.69 |
Debt / FCF | n/a |
Interest Coverage | 14.22 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 5.99% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 9.75M |
Profits Per Employee | 717,359 |
Employee Count | 831 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.87% in the last 52 weeks. The beta is 0.90, so NSE:BLISSGVS's price volatility has been similar to the market average.
Beta (5Y) | 0.90 |
52-Week Price Change | +1.87% |
50-Day Moving Average | 146.99 |
200-Day Moving Average | 131.70 |
Relative Strength Index (RSI) | 35.01 |
Average Volume (20 Days) | 571,041 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:BLISSGVS had revenue of INR 8.10 billion and earned 596.13 million in profits. Earnings per share was 5.62.
Revenue | 8.10B |
Gross Profit | 3.82B |
Operating Income | 1.06B |
Pretax Income | 982.50M |
Net Income | 596.13M |
EBITDA | 1.34B |
EBIT | 1.06B |
Earnings Per Share (EPS) | 5.62 |
Balance Sheet
The company has 2.20 billion in cash and 941.72 million in debt, giving a net cash position of 1.26 billion.
Cash & Cash Equivalents | 2.20B |
Total Debt | 941.72M |
Net Cash | 1.26B |
Net Cash Per Share | n/a |
Equity (Book Value) | 10.48B |
Book Value Per Share | 96.16 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 47.11%, with operating and profit margins of 13.05% and 7.36%.
Gross Margin | 47.11% |
Operating Margin | 13.05% |
Pretax Margin | 12.13% |
Profit Margin | 7.36% |
EBITDA Margin | 16.56% |
EBIT Margin | 13.05% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.40%.
Dividend Per Share | 0.50 |
Dividend Yield | 0.40% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.07% |
Shareholder Yield | 0.33% |
Earnings Yield | 4.79% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |